Insurers typically require documentation of inadequate glycemic control despite metformin therapy, contraindications to other agents, or presence of specific comorbidities that make GLP-1 therapy medically necessary
Despite its importance, B12 deficiency is remarkably common particularly among vegetarians, older adults, individuals with digestive conditions, and anyone whose body has difficulty absorbing this vitamin from food or oral supplements
Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction
Transitioning from Semaglutide to Tirzepatide Some patients may consider switching from Semaglutide to Tirzepatide for various reasons
Commonly prescribed GLP-1 medications for weight management include: Semaglutide (brand names include Ozempic and Wegovy) Tirzepatide (brand names include Mounjaro) Liraglutide (brand names include Saxenda and Victoza) In addition to aiding in weight loss by reducing appetite, these medications can also improve blood glucose control, which is beneficial for individuals with or at risk for type 2 diabetes
